SAREPTA THERAPEUTICS, INC. Other Current Liabilities
SAREPTA THERAPEUTICS, INC. (SRPT) had Other Current Liabilities of $16.56 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Current $16.56M.
- 2026-03-31: Other Liabilities, Current $10.38M.
- 2025-12-31: Other Liabilities, Current $11.39M.
- 2025-09-30: Other Liabilities, Current $10.17M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $16.56M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $10.38M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $11.39M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $10.17M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $10.42M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $12.97M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $13.47M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $17.29M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $17.13M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $16.27M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $17.84M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $17.95M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $16.99M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $17.38M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $15.49M 10-Q · filed 2023-11-01 | |
| 2022-09-30 | $26.21M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $16.42M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $17.80M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $15.05M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $19.03M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $18.96M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $18.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $22.14M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $15.55M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $14.84M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $12.46M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $7.84M 10-K · filed 2021-03-01 | $11.15M 10-K · filed 2020-02-26 |
| 2019-09-30 | $8.94M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $7.41M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $6.76M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $5.77M 10-K · filed 2020-02-26 | $2.46M 10-K · filed 2019-02-28 |
| 2018-09-30 | $2.00M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $2.01M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $4.72M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.39M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $1.37M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $1.34M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.38M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.30M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $1.30M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.32M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.27M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $1.28M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.37M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.26M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.19M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $1.06M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.03M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.09M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $888.00K 10-K · filed 2015-02-26 | |
| 2013-09-30 | $15.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $15.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $15.00K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $27.00K 10-K · filed 2014-03-03 | |
| 2012-09-30 | $85.00K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $107.00K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $114.00K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $126.00K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $105.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $85.00K 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $35.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |